BM3324 HCV Envelope glycoprotein E1 antibody

See related secondary antibodies

Search for all "HCV Envelope glycoprotein E1"

0.1 mg / €700.00
Please visit the country specific website of OriGene Technologies or contact your local Distributor to buy this product.

Quick Overview

Mouse anti HCV Envelope glycoprotein E1 BDI198

BM3324

Product Description for HCV Envelope glycoprotein E1

Mouse anti HCV Envelope glycoprotein E1 BDI198.
Presentation: Purified
Product is tested for Immunocytochemistry/Immunofluorescence, Frozen Sections, Enzyme Immunoassay, Western blot / Immunoblot.

Properties for HCV Envelope glycoprotein E1

Product Category Primary Antibodies
Quantity 0.1 mg
Synonyms Heptitis C Virus E1, gp32, gp35
Presentation Purified
Applications C, E, ICC/IF, WB
Clonality Monoclonal
Clone BDI198
Host Mouse
Isotype IgG
Shipping to Worldwide
PDF datasheet View Datasheet
Manufacturer OriGene Technologies GmbH
Material safety datasheet MSDS for Monoclonal Antibodies (de)

Datasheet Extract

Immunogen
Immunogen:
Recombinant HCV E1 glycoprotein (genotype 1b).
Application IFA.
ELISA.
Western blot.
Immunohistochemistry.
Background Envelope glycoproteins E1 and E2 are involved in virus attachment to the host cell as well as in virus endocytosis and fusion with host membrane. E2 inhibits human EIF2AK2/PKR activation, preventing the establishment of an antiviral state. E2 is a viral ligand for CD209/DC-SIGN and CLEC4M/DC-SIGNR, which are respectively found on dendritic cells (DCs), and on liver sinusoidal endothelial cells and macrophage-like cells of lymph node sinuses. These interactions allow capture of circulating HCV particles by these cells and subsequent transmission to permissive cells. DCs are professional antigen presenting cells, critical for host immunity by inducing specific immune responses against a broad variety of pathogens. They act as sentinels in various tissues where they entrap pathogens and convey them to local lymphoid tissue or lymph node for establishment of immunity. Capture of circulating HCV particles by these SIGN+ cells may facilitate virus infection of proximal hepatocytes and lymphocyte subpopulations and may be essential for the establishment of persistent infection.
Concentration 0.1 mg/ml (OD280 nm, E0.1% = 1.3)
Product Citations
Purchased from Acris:
  1. Tello D, Rodríguez-Rodríguez M, Yélamos B, Gómez-Gutiérrez J, Peterson DL, Gavilanes F. High-yield production of a chimeric glycoprotein based on permuted E1 and E2 HCV envelope ectodomains. J Virol Methods. 2014 Dec 5;213C:38-44. doi: 10.1016/j.jviromet.2014.11.020. PubMed PMID: 25486085.
General Readings
  1. Tani H, Komoda Y, Matsuo E, Suzuki K, Hamamoto I, Yamashita T, et al. Replication-competent recombinant vesicular stomatitis virus encoding hepatitis C virus envelope proteins. J Virol. 2007 Aug;81(16):8601-12. Epub 2007 Jun 6. PubMed PMID: 17553880. (Free PMC Article available, 8 images available)
Storage Upon receipt, store (in aliquots) at -20°C.
Avoid repeated freezing and thawing.
Shelf life: one year from despatch.
Format
Purification:
Protein A Chromatography
Buffer System:
0.01M PBS, pH 7.2 containing 0.09% Sodium Azide as preservative without stabilizing proteins
State:
Liquid purified Ig fraction from Ascites (> 90% pure)
Purified
Specificity
Specificity:
Specific to HCV E1.

Accessory Products

  • LinkedIn